Navigation path

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia


  

Published: 16 September 2016  
Related theme(s) and subtheme(s)
Health & life sciencesMajor diseases  |  Medical research  |  Public health
Research policyHorizon 2020
Special CollectionsCancer
Countries involved in the project described in the article
Austria  |  Czech Republic  |  Finland  |  France  |  Germany  |  Italy  |  Netherlands
Add to PDF "basket"

A compact device to detect the early signs of cancer

EU-funded project ULTRAPLACAD is developing a low-cost device that can detect the early signs of cancer by analysing blood. The device would allow doctors to screen more patients and provide treatment at an earlier stage of the disease - helping to save lives.

Photo of a doctor with a patient
© Photographee.eu - fotolia.com

The detection of cancer biomarkers – such as a molecule, gene or protein circulating in a body fluid – can indicate the existence of a tumour in the body. This detection method has however not been widely used mainly due to lack of available low-cost platforms that are sensitive enough to detect the presence of specific cancer biomarkers.

ULTRAPLACAD aims to overcome such barriers by developing a compact device for the detection of cancer biomarkers circulating in the blood. The device could allow doctors to screen more patients and lead to earlier diagnosis of cancer, plus an improvement in follow-up treatments after surgery on tumours.

Healthcare costs for cancer screening and treatment could also be reduced. Cancers at an early stage may be easier to treat, before they spread to other parts of the body. As well as helping to save lives, early detection and treatment could also lead to a reduction in costs for the healthcare system.

ULTRAPLACAD’s device would use a novel diagnostic system based on innovative optical analytical techniques able to detect the presence of cancer in DNA, microRNA and tumour autoantibodies carried by the blood.

The team is focusing on the detection of colorectal cancer by analysing a blood sample of just a few millilitres. It would be an alternative to performing invasive and often painful colonoscopies.

The project’s researchers hope that the method could then be developed further to detect other forms of cancer.

Colorectal cancer accounts for more than half of cancer cases recorded in Europe. Early detection of colorectal cancer through screening has been shown to reduce mortality rates, according to the project.

Project details

  • Project acronym:ULTRAPLACAD
  • Participants: Italy (Coordinator), Austria, Czech Republic, Netherlands, Germany, France, Finland
  • Project Reference N° 633937
  • Total cost: € 6 026 455
  • EU contribution: € 6 026 455
  • Duration:May 2015 - October 2018

See also

 

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project details

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center